Mind Medicine has presented positive topline data in Basel, Switzerland in April from a double-blind, investigator-initiated trial evaluating lysergide (LSD) in the treatment of Major Depressive...
Three promising studies featuring psilocybin, LSD and MDMA have shown signs of improved brain function.
More than 200 world-leading researchers in the field of psychedelics gathered at the University of Exeter for the sixth Breaking Convention.
The world’s first postgraduate course on psychedelics has been launched at the University of Exeter – an interdisciplinary programme for healthcare workers, therapists and others to...
Awakn Life Sciences and the University of Exeter (UoE) are collaborating to put in place a framework for a Phase 3 trial exploring the use of...
Filament Health and PharmAla Biotech Holdings Inc.
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a potent psychedelic compound found in the secretion from the parotid glands of the Bufo alvarius toad, native to the Sonoran Desert of...
After a sold-out conference in 2022, PSYCH Symposium is returning to bring together leading investors, regulators, scientists and industry leaders who are looking to transform the...
In 1943, Swiss chemist Albert Hofmann took the first LSD trip.
With a high demand for psychedelic facilitators, Cybin Inc.
Breaking Convention 2023 will see a panel of experts join together to discuss the benefits and risks of ketamine-assisted psychotherapy as the treatment begins to gain...
Theory: Mushrooms are an intergalactic intelligence that created consciousness in our ape ancestors.